Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2055881556', 'doi': 'https://doi.org/10.1097/qai.0b013e318183a425', 'title': 'Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects', 'display_name': 'Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects', 'publication_year': 2008, 'publication_date': '2008-12-01', 'ids': {'openalex': 'https://openalex.org/W2055881556', 'doi': 'https://doi.org/10.1097/qai.0b013e318183a425', 'mag': '2055881556', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/18989234'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/qai.0b013e318183a425', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S157460402', 'display_name': 'JAIDS Journal of Acquired Immune Deficiency Syndromes', 'issn_l': '1525-4135', 'issn': ['1525-4135', '1944-7884'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.1097/qai.0b013e318183a425', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5042918803', 'display_name': 'Sarah Robertson', 'orcid': 'https://orcid.org/0000-0002-8449-6482'}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Sarah M Robertson', 'raw_affiliation_strings': ['Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD', 'institution_ids': ['https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076255550', 'display_name': 'Frank Maldarelli', 'orcid': 'https://orcid.org/0000-0002-3062-5250'}, 'institutions': [{'id': 'https://openalex.org/I880747138', 'display_name': 'Science Applications International Corporation (United States)', 'ror': 'https://ror.org/00zv91802', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I880747138']}, {'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Frank Maldarelli', 'raw_affiliation_strings': ['HIV Drug Resistance Program and ‡Laboratory of Molecular Cell Biology, SAIC-Frederick, National Cancer Institute, Frederick, MD'], 'affiliations': [{'raw_affiliation_string': 'HIV Drug Resistance Program and ‡Laboratory of Molecular Cell Biology, SAIC-Frederick, National Cancer Institute, Frederick, MD', 'institution_ids': ['https://openalex.org/I880747138', 'https://openalex.org/I4210140884']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071752496', 'display_name': 'Ven Natarajan', 'orcid': 'https://orcid.org/0000-0002-2536-5351'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ven Natarajan', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042219898', 'display_name': 'Elizabeth Formentini', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210155647', 'display_name': 'National Institutes of Health Clinical Center', 'ror': 'https://ror.org/04vfsmv21', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210155647']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elizabeth Formentini', 'raw_affiliation_strings': ['Department of Critical Care Medicine and ‖Clinical Research Center, Department of Pharmacy, National Institutes of Health, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'Department of Critical Care Medicine and ‖Clinical Research Center, Department of Pharmacy, National Institutes of Health, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I4210155647']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056542594', 'display_name': 'Raul M. Alfaro', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Raul M Alfaro', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5019363661', 'display_name': 'Scott R. Penzak', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Scott R Penzak', 'raw_affiliation_strings': [], 'affiliations': []}], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': ['https://openalex.org/A5042918803'], 'corresponding_institution_ids': ['https://openalex.org/I1320320070'], 'apc_list': None, 'apc_paid': None, 'fwci': 1.759, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 73, 'citation_normalized_percentile': {'value': 0.90525, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '49', 'issue': '5', 'first_page': '513', 'last_page': '519'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Prenatal Exposure to Antiepileptic Drugs', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10375', 'display_name': 'Drug Metabolism and Pharmacogenomics', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bupropion', 'display_name': 'Bupropion', 'score': 0.85254616}, {'id': 'https://openalex.org/keywords/cyp2b6', 'display_name': 'CYP2B6', 'score': 0.84098893}, {'id': 'https://openalex.org/keywords/efavirenz', 'display_name': 'Efavirenz', 'score': 0.81698215}, {'id': 'https://openalex.org/keywords/cytochrome-p450', 'display_name': 'Cytochrome P450', 'score': 0.499199}, {'id': 'https://openalex.org/keywords/hydroxylation', 'display_name': 'Hydroxylation', 'score': 0.46740964}], 'concepts': [{'id': 'https://openalex.org/C2779908668', 'wikidata': 'https://www.wikidata.org/wiki/Q834280', 'display_name': 'Bupropion', 'level': 3, 'score': 0.85254616}, {'id': 'https://openalex.org/C50605568', 'wikidata': 'https://www.wikidata.org/wiki/Q14912267', 'display_name': 'CYP2B6', 'level': 5, 'score': 0.84098893}, {'id': 'https://openalex.org/C2781432083', 'wikidata': 'https://www.wikidata.org/wiki/Q422645', 'display_name': 'Efavirenz', 'level': 5, 'score': 0.81698215}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.57021517}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5692457}, {'id': 'https://openalex.org/C2781109383', 'wikidata': 'https://www.wikidata.org/wiki/Q898497', 'display_name': 'Hydroxylation', 'level': 3, 'score': 0.46740964}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3509102}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.221142}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.2159124}, {'id': 'https://openalex.org/C109650736', 'wikidata': 'https://www.wikidata.org/wiki/Q424440', 'display_name': 'CYP3A4', 'level': 4, 'score': 0.097456515}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.09533003}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.0904004}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.089799255}, {'id': 'https://openalex.org/C62231903', 'wikidata': 'https://www.wikidata.org/wiki/Q1057', 'display_name': 'Metabolism', 'level': 2, 'score': 0.068520784}, {'id': 'https://openalex.org/C526171541', 'wikidata': 'https://www.wikidata.org/wiki/Q407693', 'display_name': 'Cytochrome P450', 'level': 3, 'score': 0.068166226}, {'id': 'https://openalex.org/C2777843972', 'wikidata': 'https://www.wikidata.org/wiki/Q2462253', 'display_name': 'Smoking cessation', 'level': 2, 'score': 0.06186673}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D018687', 'descriptor_name': 'Antidepressive Agents, Second-Generation', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D001189', 'descriptor_name': 'Aryl Hydrocarbon Hydroxylases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D016642', 'descriptor_name': 'Bupropion', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D010089', 'descriptor_name': 'Oxidoreductases, N-Demethylating', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000480', 'descriptor_name': 'Alkynes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D018687', 'descriptor_name': 'Antidepressive Agents, Second-Generation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018687', 'descriptor_name': 'Antidepressive Agents, Second-Generation', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D018687', 'descriptor_name': 'Antidepressive Agents, Second-Generation', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D001189', 'descriptor_name': 'Aryl Hydrocarbon Hydroxylases', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D001189', 'descriptor_name': 'Aryl Hydrocarbon Hydroxylases', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D001189', 'descriptor_name': 'Aryl Hydrocarbon Hydroxylases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D016642', 'descriptor_name': 'Bupropion', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D016642', 'descriptor_name': 'Bupropion', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D016642', 'descriptor_name': 'Bupropion', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D016642', 'descriptor_name': 'Bupropion', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D016642', 'descriptor_name': 'Bupropion', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003521', 'descriptor_name': 'Cyclopropanes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D065702', 'descriptor_name': 'Cytochrome P-450 CYP2B6', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004790', 'descriptor_name': 'Enzyme Induction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014644', 'descriptor_name': 'Genetic Variation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006900', 'descriptor_name': 'Hydroxylation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D006900', 'descriptor_name': 'Hydroxylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010089', 'descriptor_name': 'Oxidoreductases, N-Demethylating', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D010089', 'descriptor_name': 'Oxidoreductases, N-Demethylating', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D010089', 'descriptor_name': 'Oxidoreductases, N-Demethylating', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010597', 'descriptor_name': 'Pharmacogenetics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/qai.0b013e318183a425', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S157460402', 'display_name': 'JAIDS Journal of Acquired Immune Deficiency Syndromes', 'issn_l': '1525-4135', 'issn': ['1525-4135', '1944-7884'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://journals.lww.com/jaids/Fulltext/2008/12150/Efavirenz_Induces_CYP2B6_Mediated_Hydroxylation_of.8.aspx', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036313', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/18989234', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/qai.0b013e318183a425', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S157460402', 'display_name': 'JAIDS Journal of Acquired Immune Deficiency Syndromes', 'issn_l': '1525-4135', 'issn': ['1525-4135', '1944-7884'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.6}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 35, 'referenced_works': ['https://openalex.org/W173494530', 'https://openalex.org/W1961372196', 'https://openalex.org/W1964698840', 'https://openalex.org/W1971106062', 'https://openalex.org/W1981458531', 'https://openalex.org/W199559419', 'https://openalex.org/W2007708086', 'https://openalex.org/W2009280534', 'https://openalex.org/W2012369574', 'https://openalex.org/W2017145529', 'https://openalex.org/W2022824877', 'https://openalex.org/W2035244689', 'https://openalex.org/W2035873213', 'https://openalex.org/W2055735784', 'https://openalex.org/W2066614023', 'https://openalex.org/W2071086973', 'https://openalex.org/W2072794337', 'https://openalex.org/W2084564882', 'https://openalex.org/W2095442537', 'https://openalex.org/W2098938825', 'https://openalex.org/W2108430406', 'https://openalex.org/W2109499383', 'https://openalex.org/W2110886272', 'https://openalex.org/W2115460174', 'https://openalex.org/W2119654105', 'https://openalex.org/W2125102630', 'https://openalex.org/W2128182429', 'https://openalex.org/W2131966035', 'https://openalex.org/W2135122521', 'https://openalex.org/W2147877785', 'https://openalex.org/W2165995063', 'https://openalex.org/W2336704086', 'https://openalex.org/W2414200306', 'https://openalex.org/W2755604', 'https://openalex.org/W4041946'], 'related_works': ['https://openalex.org/W4284669428', 'https://openalex.org/W2964019674', 'https://openalex.org/W2937367049', 'https://openalex.org/W2132698391', 'https://openalex.org/W2111868302', 'https://openalex.org/W2082257800', 'https://openalex.org/W2071086973', 'https://openalex.org/W2067436849', 'https://openalex.org/W2055881556', 'https://openalex.org/W1543380773'], 'abstract_inverted_index': {'Objective:': [0], 'To': [1], 'characterize': [2], 'the': [3, 79, 98, 116], 'effect': [4], 'of': [5, 13, 30, 40, 45, 85, 115, 184], 'efavirenz': [6, 41, 90, 130, 149, 166, 185], 'on': [7], 'bupropion': [8, 31, 46, 128, 147, 179], 'hydroxylation': [9, 180], 'as': [10, 173], 'a': [11, 26, 125], 'marker': [12], 'cytochrome': [14], 'P450': [15], '(CYP)': [16], '2B6': [17], 'activity': [18, 170], 'in': [19, 127, 171, 178], 'healthy': [20], 'subjects.': [21], 'Methods:': [22], 'Thirteen': [23], 'subjects': [24], 'received': [25], 'single': [27], 'oral': [28], 'dose': [29], 'SR': [32], '150': [33], 'mg': [34], 'before': [35], 'and': [36, 47, 63, 69, 103, 108, 144, 148, 155], 'after': [37, 89, 181], '2': [38, 133, 182], 'weeks': [39, 183], 'administration': [42, 91], 'for': [43, 59, 136], 'comparison': [44], 'hydroxybupropion': [48], 'pharmacokinetics.': [49], 'Efavirenz': [50], 'plasma': [51], 'concentrations': [52], 'were': [53, 57, 122], 'also': [54], 'assessed.': [55], 'Subjects': [56], 'genotyped': [58], 'CYP2B6': [60, 117, 168], '(G516T,': [61], 'C1459T,': [62], 'A785G),': [64], 'CYP3A4': [65], '(A-392G),': [66], 'CYP3A5': [67], '(A6986G),': [68], 'multidrug': [70, 137], 'resistance': [71, 138], 'protein': [72, 139], '1': [73, 140], '(C3435T).': [74], 'Results:': [75], 'The': [76, 132], 'area': [77, 96], 'under': [78, 97], 'concentration': [80, 99], 'vs.': [81, 100], 'time': [82, 101], 'curve': [83, 102], 'ratio': [84], 'hydroxybupropion:bupropion': [86], 'increased': [87], '2.3-fold': [88], '(P': [92, 111, 158], '=': [93], '0.0001).': [94], 'Bupropion': [95], 'Cmax': [104], 'decreased': [105], 'by': [106, 175], '55%': [107], '34%,': [109], 'respectively': [110], '<': [112, 159], '0.002).': [113], 'None': [114], 'or': [118, 129], 'CYP3A': [119], 'genotypes': [120], 'evaluated': [121], 'associated': [123], 'with': [124], 'difference': [126], 'clearance.': [131], 'individuals': [134, 157], 'homozygous': [135], '3435-T/T': [141], 'had': [142], '2.5-': [143], '1.8-fold': [145], 'greater': [146], 'clearance,': [150], 'respectively,': [151], 'relative': [152], 'to': [153], 'C/C': [154], 'C/T': [156], '0.05).': [160], 'Conclusions:': [161], 'Our': [162], 'results': [163], 'confirm': [164], 'that': [165], 'induces': [167], 'enzyme': [169], 'vivo,': [172], 'demonstrated': [174], 'an': [176], 'increase': [177], 'administration.': [186]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2055881556', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 4}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 5}, {'year': 2016, 'cited_by_count': 11}, {'year': 2015, 'cited_by_count': 10}, {'year': 2014, 'cited_by_count': 4}, {'year': 2013, 'cited_by_count': 10}, {'year': 2012, 'cited_by_count': 6}], 'updated_date': '2024-09-10T18:51:02.989648', 'created_date': '2016-06-24'}